1. Home
  2. BDSX vs HYI Comparison

BDSX vs HYI Comparison

Compare BDSX & HYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$14.59

Market Cap

143.2M

Sector

Health Care

ML Signal

HOLD

Logo Western Asset High Yield Defined Opportunity Fund Inc.

HYI

Western Asset High Yield Defined Opportunity Fund Inc.

HOLD

Current Price

$10.58

Market Cap

135.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDSX
HYI
Founded
2005
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
143.2M
135.2M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
BDSX
HYI
Price
$14.59
$10.58
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$32.50
N/A
AVG Volume (30 Days)
64.7K
62.2K
Earning Date
05-04-2026
01-01-0001
Dividend Yield
N/A
9.59%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$88,499,000.00
N/A
Revenue This Year
$25.26
N/A
Revenue Next Year
$19.15
N/A
P/E Ratio
N/A
N/A
Revenue Growth
24.08
N/A
52 Week Low
$0.26
$10.44
52 Week High
$20.21
$12.12

Technical Indicators

Market Signals
Indicator
BDSX
HYI
Relative Strength Index (RSI) 55.64 39.00
Support Level $13.46 $10.44
Resistance Level $16.38 $11.20
Average True Range (ATR) 1.00 0.08
MACD 0.08 -0.02
Stochastic Oscillator 42.83 18.48

Price Performance

Historical Comparison
BDSX
HYI

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

About HYI Western Asset High Yield Defined Opportunity Fund Inc.

Western Asset High Yield Defined Opps. is a non-diversified, limited-term, closed-end management investment company. The company's investment objective is to provide high income and seek capital appreciation. The fund invests a majority of its net assets in a portfolio of high-yield corporate fixed-income securities issued or originated by U.S. or foreign public or private corporations and other business entities, with varying maturities.

Share on Social Networks: